10

Recurrent Esophageal Cancer

All recurrent esophageal cancer patients present difficult problems in palliation. All patients, whenever possible, should be considered candidates for clinical trials as outlined in treatment overview.

Standard treatment options:

Palliative use of any of the standard therapies, including supportive care.

Treatment options under clinical evaluation:

Clinical trials.

Current Clinical Trials

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent esophageal cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site.

< Previous Section  | Next Section >
本站由 中国医学科学院医学信息研究所创办并维护 未经许可禁止转载或建立镜像